&

Nevro completes $58 million financing round

Friday, July 22, 2011 10:22 AM

Nevro, a neuromodulation company focused on relief of chronic pain, has completed a $58 million financing round led by new investor Johnson & Johnson Development (JJDC). Existing investors Aberdare Ventures, Accuitive Medical Ventures, Bay City Capital, Mayo Clinic, MPM Capital and Three Arch Partners also participated.

More... »

Express Scripts to buy Medco Health Solutions for $29 billion

Thursday, July 21, 2011 12:52 PM

Express Scripts will buy rival Medco Health Solutions, parent company of United BioSource Corp., for $29.1 billion, creating a U.S. powerhouse in managing prescription drug benefits, the companies said, according to Reuters.

More... »

Valeant buys Johnson & Johnson skincare unit for $345 million

Tuesday, July 19, 2011 12:57 PM

Valeant Pharmaceuticals wants to become the world's biggest player in the skincare sector in about five years, its top executive told Reuters. The company has been signaling its intent with a string of recent mid-sized acquisitions in the highly fragmented but lucrative dermatology sector.

More... »

PPD shares rise on takeover rumors

Monday, July 18, 2011 01:51 PM

Shares of CRO Pharmaceutical Product Development (PPD) rose 16% to levels not touched in more than two-and-a-half years on Monday, a day after a Wall Street Journal report said the company was looking to sell itself, reported Reuters.

More... »

Vetter receives Frost & Sullivan award

Friday, July 15, 2011 10:50 AM

Vetter has received the Frost & Sullivan 2011 European Prefilled Injection Systems Customer Service Leadership Award. The international consulting company recognized Vetter for best practices in its collaboration with global customers; in particular, the quality of service the company creates for its partners. Vetter provides support from early development of drugs through regulatory approval and market supply worldwide.

More... »

InSite Vision raises $22.2 million

Thursday, July 14, 2011 12:28 PM

InSite Vision has entered into a private placement financing transaction of approximately $22.2 million in exchange for the issuance of approximately 37 million shares of InSite Vision common stock and warrants to purchase approximately 14.8 million shares of InSite Vision common stock.

More... »

Vince & Associates opens neuropsychiatric research center

Thursday, July 14, 2011 12:21 PM

Vince & Associates Clinical Research, a provider of early development clinical trials, has opened the Neuropsychiatric Research Center in Overland Park, Kan.

More... »

Gilead to allow generic AIDS drugs through Medicines Patent Pool

Wednesday, July 13, 2011 10:46 AM

Gilead Sciences will allow some of its AIDS drugs to be made by generic manufacturers, potentially increasing their availability in poor countries, particularly in Africa, according to the Associated Press.

More... »

FDA eases rules for Alzheimer’s experiments to speed new treatments for dementia

Tuesday, July 12, 2011 12:35 PM

The FDA is making it easier to test new Alzheimer’s drugs, hoping to speed progress toward new treatments for the mind-robbing disease, according to an Associated Press report.

More... »

Report of flat R&D pipeline: good news amid economic woes or sign of more turmoil ahead?

Tuesday, July 5, 2011 08:02 AM

The research and development pipeline has officially flattened out.

More... »